Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 13, 2025 • 10:31 PM ET

Date/Time Source News Release
05/06/2025 04:05 PM EDT GlobeNewswire Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
05/01/2025 07:30 AM EDT GlobeNewswire Prelude Therapeutics to Participate in Citizens Life Sciences Conference
04/25/2025 04:05 PM EDT GlobeNewswire Prelude Announces Presentations at 2025 AACR Annual Meeting
03/10/2025 07:30 AM EDT GlobeNewswire Prelude Therapeutics Reports Full Year 2024 Financial Results and Provides Program Outlook for 2025
03/05/2025 07:30 AM EST GlobeNewswire Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference
12/11/2024 07:30 AM EST GlobeNewswire Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignancies
11/27/2024 07:30 AM EST GlobeNewswire Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit
11/06/2024 04:05 PM EST GlobeNewswire Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/24/2024 07:30 AM EDT GlobeNewswire Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium
10/09/2024 07:30 AM EDT GlobeNewswire Prelude Therapeutics Announces Publication of Abstracts for Presentation at the 36th EORTC-NCI-AACR Symposium
Page
  • 1

Additional News

As of May 13, 2025 • 10:31 PM ET

Date/Time Source News Release
05/06/2025 05:20 PM EDT SeekingAlpha Prelude Therapeutics GAAP EPS of -$0.42 beats by $0.05
05/06/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 6th, 2025
05/06/2025 05:31 AM EDT US Earnings Reports Expected earnings - Prelude Therapeutics Incorporated
04/10/2025 12:00 PM EDT Zacks Prelude Therapeutics (PRLD) Upgraded to Buy: Here's What You Should Know
03/10/2025 03:36 PM EDT SeekingAlpha Prelude Therapeutics GAAP EPS of $1.68
03/06/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, March 6th, 2025
03/06/2025 04:31 AM EST US Earnings Reports Expected earnings - Prelude Therapeutics Incorporated
02/27/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, February 27th, 2025
02/27/2025 04:30 AM EST US Earnings Reports Expected earnings - Prelude Therapeutics Incorporated
02/20/2025 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, February 20th, 2025
Page
  • 1
  • 2

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.